Medicare increasing the reimbursement rate will encourage more innovative delivery methods for the provision of COVID-19 vaccinations to underserved populations. This increase will encourage more investment in these vaccination efforts. We continue to advise clinical and ancillary providers as they create partnerships and collaborative relationships to address the gaps in care exposed by this crisis. I believe these types of efforts, in conjunction with the overall drive towards value based care, will inform the future of healthcare in the United States.